
| Code | Product | Strength | Indication | GMP | Registration |
|---|---|---|---|---|---|
| UB907 | Riluzole Tablets | 50mg | Amyotrophic lateral sclerosis | CN - NMPA | China |
| UB833 | Eltrombopag Olamine Tablet | 12.5mg, 25mg, 50mg, 75mg | Refractory immune thrombocytopenia; Severe aplastic anaemia | US - FDA; CN - NMPA | China |
| UB771 | Inpegsomatropin Injection | 2.5mg/0.35mL/PFS; 3.0mg/0.35mL/PFS; 3.5mg/0.35mL/PFS; 5.0mg/0.35mL/PFS; | Growth hormone deficiency | CN - NMPA | China |
| UB735 | Lanreotide Acetate injectables | / | Acromegaly | EU - EMA; US - FDA | China |
| UB547 | Tolazoline Mesylate Injection | 1ml:10mg | Phaeochromocytoma; Extravasation; Left ventricular failure | CN - NMPA | China |
获取最新活动与法规动态洞察
直接发送到您的邮箱
在此获取行业洞察与 Unibest 动态
联系我们 →